AGTX · Agentix Corp.
Market Cap
$801,339
Shares
40.07M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
-100%
FY2023
Net Income
-$485.64K
+14.4%
FY2026
Gross Margin
54.76%
0pp
FY2022
Operating Margin
-211825.08%
-103677.4pp
FY2022
Diluted EPS
-$0.01
0%
FY2026
Operating Cash Flow
-$108.53K
+13.2%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | $0 | $1240 | $1240 | — | $2250 | $2250 | $43.14K | $28.38K | |
| — | — | — | — | — | — | — | — | $24.82K | — | — | — | |
| — | — | — | — | $0 | $561 | $561 | — | $1357 | $1357 | $1357 | $2036 | |
| — | — | — | — | $0 | $679 | $679 | — | $893 | $893 | $41.79K | $26.34K | |
| — | — | — | — | — | 54.76% | 54.76% | — | 39.69% | 39.69% | 96.85% | 92.82% | |
| $41.71K | $125.08K | $180.99K | $175.27K | $711.51K | $279.91K | $365.13K | — | — | $3692 | $3692 | $28.33K | |
| $67.14K | $68.07K | $69.9K | $346.54K | $140.01K | $165.36K | $66.42K | $3995 | $8783 | $23.68K | $23.01K | $36.26K | |
| — | — | — | — | — | — | — | — | — | $189 | $189 | $189 | |
| $340.35K | $445.19K | $513.25K | $744.81K | $1.37M | $2.63M | $1.34M | $121.32K | $134.38K | $334.88K | $334.22K | $201.47K | |
| -$340.35K | -$445.19K | -$513.25K | -$744.81K | -$1.37M | -$2.63M | -$1.34M | -$121.32K | -$134.38K | -$333.99K | -$295.64K | -$175.13K | |
| — | — | — | — | — | -211825.08% | -108147.66% | — | — | -14844% | -685.25% | -617.18% | |
| $81.05K | $80.11K | $42.67K | $21.03K | $1643 | — | — | $11.34K | — | $13.34K | — | — | |
| — | — | -$53.8K | $159.66K | $2049 | — | -$5 | — | $42.65M | $47.11K | -$3205 | — | |
| -$417.49K | -$485.64K | -$567.05K | -$585.15K | -$1.37M | — | -$1.34M | -$132.65K | — | -$381.1K | — | — | |
| $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | — | — | — | — | |
| -$417.49K | -$485.64K | -$567.05K | -$585.15K | -$1.37M | -$2.63M | -$1.34M | -$132.65K | -$42.79M | -$381.1K | -$295.64K | -$175.13K | |
| — | — | — | — | — | -211825.08% | -108092.5% | — | — | -16937.82% | -685.25% | -617.18% | |
| -$427.36K | -$476.6K | -$602.22K | -$573.56K | -$1.37M | — | — | — | — | — | — | — | |
| USD/shares | -$0.01 | -$0.01 | -$0.01 | -$0.01 | — | — | — | — | — | — | -$0.00 | — |
| shares | — | — | — | — | — | — | 34.73M | 2.06M | 1.1B | 601.74M | 601.99M | 595.95M |
| shares | — | 40.07M | 40.07M | 40.07M | — | — | 34.73M | 2.06M | 1.1B | 601.74M | 601.99M | 595.95M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 2.02×
EV/EBIT
—
P/E (TTM)
—
Peer medians compare against the 66 similar-size Biotechnology companies (of 514 listed).